483 Neelakantan Anand, MD Oct 2019

483 Neelakantan Anand, MD Oct 2019

Mark Babbitt FDA$119.00 - Available Now

FDA investigators audited the Neelakantan Anand, MD - Los Angeles, CA, United States facility and issued inspectional observations (via FDA 483) on 24 Oct 2019.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 24 Oct 2019
  • Location: Los Angeles, United States
  • FEI: 3015533953
Add To Cart